Pragmatech, a Spanish HealthTech startup focused on AI solutions in pharmacology, microbiology, and infectious diseases, has raised €650k in funding to boost the commercial deployment of iAST®, its antibiotic prescribing software that obtained CE marking in July 2025.
The round was led by First Drop, which invested €300k, and included Urriellu Ventures with €175k. The round also comprised an ENISA loan of €180k and the conversion into equity of €162,500 in convertible notes from a previous round.
Pragmatech is an Oviedo-based startup founded in 2021. According to the company, its flagship product, iAST®, is the first CE-marked AI-powered software designed to support clinical decision-making in antibiotic prescription. It has been clinically proven to reduce prescribing errors and recommend treatments with lower resistance potential, it claims.
“With this funding round, we are strengthening our ability to bring iAST® to the hospitals and healthcare professionals who need it most. The support of investors like First Drop and Urriellu Ventures reinforces confidence in our technology and the positive impact it is having on clinical practice,” said Javier Fernández, co-CEO of Pragmatech.
With a B2B model, the company aims to lead the digital transformation of infectious disease management, enhancing patient outcomes and healthcare system sustainability.
Pablo Valledor, co-CEO and CTO, said, “This funding not only enables us to roll out iAST® at a commercial level, but also provides us with the resources necessary to continue refining our products and to ensure that artificial intelligence supports clinical decision-making in a safe and effective manner.”
Read the orginal article: https://www.eu-startups.com/2025/12/spanish-healthtech-pragmatech-raises-e650k-to-roll-out-its-ce-marked-ai-antibiotic-prescribing-software/
